1 October 2015. KEI Europe, as a member of the Coalition for Affordable T-DM1, submitted a letter to the UK government requesting the government to take several actions to make the breast cancer drug T-DM1 (trastuzumab emtansine) more affordable. The drug made by Roche (trade name Kadcyla) was declared too expensive for the NHS to provide and was only available in England through the Cancer Drug Fund.
Information regarding the problem, the request, and how you can get involved:
Press Release. "Coalition for Affordable T-DM1 Asks the Government to Employ Crown Use Authority to Lower Price of Expensive Cancer Drug."